Ebola, Childhood Cancers, And Chronic Pain: IMI's New R&D Ventures
This article was originally published in Scrip
Executive Summary
Europe's Innovative Medicines Initiative (IMI) has launched two calls for proposals, one of which allots €70m ($76m) for research into Ebola, specifically the development of vaccines, treatments and diagnostic tests to improve responses to future outbreaks of Ebola or related diseases.